Yahoo
Frankfurt - Delayed Quote EUR

WELL Health Technologies Corp. (W7V.F)

2.5330 -0.1180 (-4.45%)
As of 8:02:11 AM GMT+1. Market Open.
Chart Range Bar
Loading chart for W7V.F
  • Previous Close 2.6510
  • Open 2.5330
  • Bid 2.6670 x --
  • Ask 2.7070 x --
  • Day's Range 2.5330 - 2.5330
  • 52 Week Range 2.1880 - 3.1480
  • Volume 1,500
  • Avg. Volume 164
  • Market Cap (intraday) 648.314M
  • Beta (5Y Monthly) 1.21
  • PE Ratio (TTM) 253.30
  • EPS (TTM) 0.0100
  • Earnings Date Nov 9, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions, such as DoctorCare, ClinicAid, and PatientServ; OceanMD, an EMR-integrated patient engagement solutions; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, AwareMD, and Healthquest EMR systems. WELL Health Technologies Corp. was founded in 2010 and is headquartered in Vancouver, Canada.

well.company

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

W7V.F
8.62%
S&P/TSX Composite index (^GSPTSE)
12.26%

1-Year Return

W7V.F
21.36%
S&P/TSX Composite index (^GSPTSE)
18.53%

3-Year Return

W7V.F
2.55%
S&P/TSX Composite index (^GSPTSE)
89.70%

5-Year Return

W7V.F
44.19%
S&P/TSX Composite index (^GSPTSE)
70.04%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 400.43M
Earnings -10.91M
Profit Margin -2.73%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
100M
200M
300M
400M
-2.0%
0.0%
2.0%
4.0%
6.0%

Statistics

View More

Valuation Measures

Annual
As of 10/28/2026
  • Market Cap

    677.60M

  • Enterprise Value

    1.21B

  • Trailing P/E

    210.82

  • Forward P/E

    11.37

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    0.71

  • Price/Book (mrq)

    1.41

  • Enterprise Value/Revenue

    1.29

  • Enterprise Value/EBITDA

    10.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.25%

  • Return on Assets (ttm)

    2.65%

  • Return on Equity (ttm)

    1.63%

  • Revenue (ttm)

    1.52B

  • Net Income Avi to Common (ttm)

    3.77M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    130.64M

  • Total Debt/Equity (mrq)

    95.43%

  • Levered Free Cash Flow (ttm)

    1.65M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: